ArticleScientific reports2023

Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform.

Steven D Forsythe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.